Trials / Unknown
UnknownNCT02319876
Expression of TIM-3 on Lymphocytes in Sepsis
Expression and the Clinical Significance of TIM-3 on Lymphocytes During Sepsis
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (estimated)
- Sponsor
- Changhai Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The current project was designed to examine the express TIM-3 on lymphocytes and monocytes and its role in immunosuppression during sepsis.
Detailed description
Immunosuppression is the leading cause of death in septic patients.Lymphocyte apoptosis has been recognized as an important step in the pathogenesis of sepsis. Previous studies indicated that T cell immunoglobulin and mucin protein 3 (TIM-3) is a type I cell surface protein and was identified as a marker of lymphocyte dysfunction. The current project was designed to examine the express TIM-3 on lymphocytes and monocytes and its further role in immunosuppression during sepsis.
Conditions
Timeline
- Start date
- 2014-02-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2014-12-18
- Last updated
- 2015-07-29
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02319876. Inclusion in this directory is not an endorsement.